BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2991397)

  • 1. [Studies on immunosuppressive acidic protein (IAP) in ovarian tumors].
    Miyoshi T; Nishimura H; Hamai J; Yamada T; Tomoo Y; Kobayashi H; Yakushiji M; Kato T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):923-9. PubMed ID: 2991397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of immunosuppressive acidic protein in the diagnosis and follow-up of patients with ovarian cancer, in particular as a marker for chemotherapeutic effects].
    Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Apr; 38(4):554-60. PubMed ID: 3701144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive acidic protein in patients with gynecologic cancer].
    Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
    Takada M
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
    Koebl H; Tatra G; Bieglmayer C
    Neoplasma; 1988; 35(2):215-20. PubMed ID: 3259680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Immunosuppressive acidic protein" (IAP)--an improvement for tumor marker diagnosis in epithelial ovarian cancer?].
    Sevelda P; Haider F; Spona J
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):452-5. PubMed ID: 3476335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
    Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases].
    Okada S; Kirime S; Kawasaki T; Kanbara A; Kanehara H; Takasaki N; Miyazaki S; Inai S
    Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
    Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of serum immunosuppresive acidic protein levels in gynecological tumor].
    Zhang W; Wang P; Zhao Y
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):194-6. PubMed ID: 11601039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and prognosis of mucinous tumors of the ovary.
    Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
    Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
    Kondo H; Seno N; Matsuo S; Otagaki S; Matsuki T; Hatayama T
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Watanabe H; Yokoe T; Hiro J; Ojima E; Tanaka K; Kusunoki M
    J Surg Oncol; 2008 Apr; 97(5):404-8. PubMed ID: 18181167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].
    Kikuchi S
    Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):283-99. PubMed ID: 6749105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunosuppressive acidic protein levels in patients with severe acute pancreatitis.
    Shinzeki M; Ueda T; Takeyama Y; Yasuda T; Sawa H; Nakajima T; Matsumoto I; Fujita T; Ajiki T; Fujino Y; Kuroda Y
    Pancreas; 2007 Nov; 35(4):327-33. PubMed ID: 18090238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
    Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
    J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive acidic protein in patients with ovarian cancer.
    Sawada M; Okudaira Y; Matsui Y; Shimizu Y
    Cancer; 1983 Dec; 52(11):2081-5. PubMed ID: 6627216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer].
    Shibayama T; Nakazono M; Koyama Y; Deguchi N; Baba S; Jitsukawa S; Murai M; Tazaki H
    Gan No Rinsho; 1984 May; 30(5):481-6. PubMed ID: 6727048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.